CDHR2
geneOn this page
Also known as PC-LKCFLJ20124FLJ20383PCLKC
Summary
CDHR2 (cadherin related family member 2, HGNC:18231) is a protein-coding gene on chromosome 5q35.2, encoding Cadherin-related family member 2 (Q9BYE9). Intermicrovillar adhesion molecule that forms, via its extracellular domain, calcium-dependent heterophilic complexes with CDHR5 on adjacent microvilli.
This gene is a member of the protocadherin family, which represents a subset of the larger cadherin superfamily. The members of the protocadherin family encode non-classical cadherins that function as calcium-dependent cell-cell adhesion molecules. This protocadherin represents a new candidate for tumor suppression. Alternatively spliced transcript variants that encode the same protein have been identified.
Source: NCBI Gene 54825 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 281 total — 2 pathogenic
- MANE Select transcript:
NM_017675
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18231 |
| Approved symbol | CDHR2 |
| Name | cadherin related family member 2 |
| Location | 5q35.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PC-LKC, FLJ20124, FLJ20383, PCLKC |
| Ensembl gene | ENSG00000074276 |
| Ensembl biotype | protein_coding |
| OMIM | 619713 |
| Entrez | 54825 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 13 protein_coding, 4 retained_intron, 1 nonsense_mediated_decay
ENST00000261944, ENST00000416365, ENST00000506348, ENST00000508085, ENST00000510124, ENST00000510636, ENST00000513031, ENST00000888592, ENST00000888593, ENST00000888594, ENST00000888595, ENST00000888596, ENST00000888597, ENST00000888598, ENST00000888599, ENST00000888600, ENST00000888601, ENST00000955721
RefSeq mRNA: 2 — MANE Select: NM_017675
NM_001171976, NM_017675
CCDS: CCDS34297
Canonical transcript exons
ENST00000261944 — 32 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000973824 | 176565672 | 176565743 |
| ENSE00000973825 | 176568678 | 176568817 |
| ENSE00000973826 | 176568960 | 176569010 |
| ENSE00000973827 | 176571213 | 176571302 |
| ENSE00000973828 | 176574083 | 176574172 |
| ENSE00000973840 | 176584190 | 176584259 |
| ENSE00000973841 | 176584410 | 176585015 |
| ENSE00000973842 | 176585954 | 176586025 |
| ENSE00000973843 | 176586793 | 176586842 |
| ENSE00001055406 | 176575724 | 176575839 |
| ENSE00001055412 | 176590563 | 176590687 |
| ENSE00001055414 | 176575280 | 176575426 |
| ENSE00001055415 | 176575084 | 176575209 |
| ENSE00001055420 | 176577399 | 176577554 |
| ENSE00001055423 | 176581343 | 176581582 |
| ENSE00001055427 | 176575506 | 176575581 |
| ENSE00001129085 | 176565338 | 176565404 |
| ENSE00001159367 | 176578365 | 176578608 |
| ENSE00001159418 | 176577637 | 176577798 |
| ENSE00001196538 | 176591404 | 176591484 |
| ENSE00001196573 | 176578034 | 176578095 |
| ENSE00001431143 | 176549342 | 176549414 |
| ENSE00001507332 | 176595532 | 176595824 |
| ENSE00001507333 | 176592723 | 176592780 |
| ENSE00001507334 | 176575952 | 176576185 |
| ENSE00003470241 | 176590078 | 176590146 |
| ENSE00003509115 | 176590425 | 176590485 |
| ENSE00003527350 | 176589330 | 176589438 |
| ENSE00003528588 | 176591210 | 176591323 |
| ENSE00003547257 | 176589031 | 176589182 |
| ENSE00003601680 | 176589528 | 176589616 |
| ENSE00003649482 | 176590253 | 176590330 |
Expression profiles
Bgee: expression breadth ubiquitous, 176 present calls, max score 98.99.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.5806 / max 1012.3984, expressed in 47 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 60420 | 1.4149 | 41 |
| 60419 | 0.1107 | 27 |
| 60425 | 0.0459 | 3 |
| 60423 | 0.0062 | 3 |
| 60424 | 0.0029 | 2 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| jejunal mucosa | UBERON:0000399 | 98.99 | gold quality |
| ileal mucosa | UBERON:0000331 | 97.16 | gold quality |
| duodenum | UBERON:0002114 | 96.99 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 92.87 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 91.49 | gold quality |
| small intestine | UBERON:0002108 | 91.04 | gold quality |
| cortical plate | UBERON:0005343 | 89.43 | gold quality |
| rectum | UBERON:0001052 | 88.84 | gold quality |
| left testis | UBERON:0004533 | 88.00 | gold quality |
| right lobe of liver | UBERON:0001114 | 87.48 | gold quality |
| sperm | CL:0000019 | 86.73 | gold quality |
| jejunum | UBERON:0002115 | 86.39 | gold quality |
| colonic mucosa | UBERON:0000317 | 86.38 | gold quality |
| liver | UBERON:0002107 | 86.31 | gold quality |
| right testis | UBERON:0004534 | 86.27 | gold quality |
| transverse colon | UBERON:0001157 | 85.38 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 84.64 | gold quality |
| male germ cell | CL:0000015 | 84.44 | gold quality |
| testis | UBERON:0000473 | 84.29 | gold quality |
| right frontal lobe | UBERON:0002810 | 83.40 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 83.35 | gold quality |
| cingulate cortex | UBERON:0003027 | 83.21 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.17 | gold quality |
| amygdala | UBERON:0001876 | 81.71 | gold quality |
| pancreatic ductal cell | CL:0002079 | 81.68 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 81.62 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.60 | gold quality |
| islet of Langerhans | UBERON:0000006 | 81.28 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.78 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.54 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-125970 | yes | 67.64 |
| E-ANND-3 | yes | 11.23 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- suppression of beta-catenin signaling by PCDH24 leads to contact inhibition (PMID:19383367)
- CDHR24 is directly involved in cell and tissue morphogenesis (PMID:22628312)
- Study found that brush border assembly is driven by the formation of Ca(2+)-dependent adhesion links between adjacent microvilli. Intermicrovillar links are composed of protocadherin-24 and mucin-like protocadherin, which target to microvillar tips and interact to form a trans-heterophilic complex. (PMID:24725409)
- Heterophilic and homophilic cadherin interactions in intestinal intermicrovillar links are species dependent. (PMID:34871294)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cdhr2 | ENSMUSG00000034918 |
| rattus_norvegicus | Cdhr2 | ENSRNOG00000017917 |
Paralogs (33): CDH1 (ENSG00000039068), CDH10 (ENSG00000040731), CDH3 (ENSG00000062038), CDH19 (ENSG00000071991), CDH17 (ENSG00000079112), CDH7 (ENSG00000081138), PCDH11Y (ENSG00000099715), CDHR5 (ENSG00000099834), CDH20 (ENSG00000101542), PCDH11X (ENSG00000102290), CDH23 (ENSG00000107736), CDH9 (ENSG00000113100), CDH6 (ENSG00000113361), CDH26 (ENSG00000124215), CDHR3 (ENSG00000128536), CDH15 (ENSG00000129910), CDH24 (ENSG00000139880), CDH11 (ENSG00000140937), CDH13 (ENSG00000140945), CDH18 (ENSG00000145526), CDHR1 (ENSG00000148600), CDH22 (ENSG00000149654), CDH8 (ENSG00000150394), CDH12 (ENSG00000154162), PCDH1 (ENSG00000156453), DCHS1 (ENSG00000166341), PCDH7 (ENSG00000169851), CDH2 (ENSG00000170558), CDH4 (ENSG00000179242), CDH5 (ENSG00000179776), PCDH9 (ENSG00000184226), DCHS2 (ENSG00000197410), PCDH20 (ENSG00000280165)
Protein
Protein identifiers
Cadherin-related family member 2 — Q9BYE9 (reviewed: Q9BYE9)
Alternative names: Protocadherin LKC, Protocadherin-24
All UniProt accessions (2): Q9BYE9, D6REJ3
UniProt curated annotations — full annotation on UniProt →
Function. Intermicrovillar adhesion molecule that forms, via its extracellular domain, calcium-dependent heterophilic complexes with CDHR5 on adjacent microvilli. Thereby, controls the packing of microvilli at the apical membrane of epithelial cells. Through its cytoplasmic domain, interacts with microvillus cytoplasmic proteins to form the intermicrovillar adhesion complex/IMAC. This complex plays a central role in microvilli and epithelial brush border differentiation. May also play a role in cell-cell adhesion and contact inhibition in epithelial cells.
Subunit / interactions. Part of the IMAC/intermicrovillar adhesion complex/intermicrovillar tip-link complex composed of ANKS4B, MYO7B, USH1C, CDHR2 and CDHR5. Interacts with MAST2. Interacts (via cytoplasmic domain) with USH1C and MYO7B; required for proper localization of CDHR2 to microvilli tips and its function in brush border differentiation.
Subcellular location. Apical cell membrane. Cell projection. Microvillus membrane. Cell junction.
Tissue specificity. Highly expressed in liver, kidney and colon. Moderately expressed in small intestine. Down-regulated in a number of liver and colon cancers. Expressed in duodenum with higher expression in enterocytes along the villus axis and lower expression in crypts (at protein level).
Domain organisation. The cadherin 1 domain is required for binding to CDHR5.
RefSeq proteins (2): NP_001165447, NP_060145* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002126 | Cadherin-like_dom | Domain |
| IPR015919 | Cadherin-like_sf | Homologous_superfamily |
| IPR020894 | Cadherin_CS | Conserved_site |
Pfam: PF00028
UniProt features (81 total): glycosylation site 24, strand 18, domain 9, sequence variant 9, helix 4, turn 3, region of interest 2, compositionally biased region 2, modified residue 2, topological domain 2, sequence conflict 2, signal peptide 1, chain 1, transmembrane region 1, mutagenesis site 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 5CZR | X-RAY DIFFRACTION | 2.3 |
| 7N86 | X-RAY DIFFRACTION | 3.17 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYE9-F1 | 80.84 | 0.31 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 1248, 1299
Glycosylation sites (24): 29, 134, 182, 188, 195, 300, 355, 371, 401, 460, 565, 600, 616, 632, 680, 696, 701, 775, 821, 871 …
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 1310 | loss of interaction with ush1c. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 93 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH, GOBP_GROWTH, GOBP_NEUROGENESIS, GOBP_CELL_CELL_ADHESION, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, MODULE_205, ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN, GOCC_APICAL_PLASMA_MEMBRANE, GOBP_DETECTION_OF_STIMULUS, GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION, GOBP_HOMOTYPIC_CELL_CELL_ADHESION, GOBP_CELL_PROJECTION_ORGANIZATION, BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP
GO Biological Process (12): homophilic cell-cell adhesion (GO:0007156), axonogenesis (GO:0007409), epithelial cell differentiation (GO:0030855), regulation of microvillus length (GO:0032532), cell-cell adhesion mediated by cadherin (GO:0044331), negative regulation of cell growth involved in contact inhibition (GO:0060243), intermicrovillar adhesion (GO:0090675), brush border assembly (GO:1904970), cell adhesion (GO:0007155), cell differentiation (GO:0030154), epithelium development (GO:0060429), cell-cell adhesion (GO:0098609)
GO Molecular Function (3): calcium ion binding (GO:0005509), cell adhesion molecule binding (GO:0050839), protein binding (GO:0005515)
GO Cellular Component (11): plasma membrane (GO:0005886), microvillus (GO:0005902), brush border (GO:0005903), adherens junction (GO:0005912), apical plasma membrane (GO:0016324), brush border membrane (GO:0031526), microvillus membrane (GO:0031528), extracellular exosome (GO:0070062), membrane (GO:0016020), cell projection (GO:0042995), anchoring junction (GO:0070161)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell-cell adhesion | 2 |
| microvillus | 2 |
| apical part of cell | 2 |
| cell projection membrane | 2 |
| cellular anatomical structure | 2 |
| cell morphogenesis involved in neuron differentiation | 1 |
| neuron projection morphogenesis | 1 |
| axon development | 1 |
| cell differentiation | 1 |
| epithelium development | 1 |
| regulation of microvillus organization | 1 |
| regulation of cell projection size | 1 |
| negative regulation of cell growth | 1 |
| contact inhibition | 1 |
| homotypic cell-cell adhesion | 1 |
| brush border assembly | 1 |
| cellular component assembly | 1 |
| cellular process | 1 |
| cellular developmental process | 1 |
| tissue development | 1 |
| cell adhesion | 1 |
| metal ion binding | 1 |
| protein binding | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| actin filament bundle | 1 |
| actin-based cell projection | 1 |
| cluster of actin-based cell projections | 1 |
| cell-cell junction | 1 |
| plasma membrane region | 1 |
| brush border | 1 |
| apical plasma membrane | 1 |
| extracellular vesicle | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
894 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CDHR2 | CDHR5 | Q9HBB8 | 991 |
| CDHR2 | E9PNW1 | E9PNW1 | 828 |
| CDHR2 | ANKS4B | Q8N8V4 | 790 |
| CDHR2 | MYO7B | Q6PIF6 | 790 |
| CDHR2 | GPRIN1 | Q7Z2K8 | 566 |
| CDHR2 | KNDC1 | Q76NI1 | 518 |
| CDHR2 | ADGRA1 | Q86SQ6 | 476 |
| CDHR2 | ESPN | B1AK53 | 463 |
| CDHR2 | IGDCC4 | Q8TDY8 | 433 |
| CDHR2 | CDHR4 | A6H8M9 | 432 |
| CDHR2 | PCDH15 | Q96QU1 | 420 |
| CDHR2 | ACRV1 | P26436 | 417 |
| CDHR2 | OR8A1 | Q8NGG7 | 410 |
| CDHR2 | RAB24 | Q969Q5 | 398 |
| CDHR2 | TMEM164 | Q5U3C3 | 391 |
IntAct
22 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CDHR2 | CDHR5 | psi-mi:“MI:0407”(direct interaction) | 0.590 |
| CDHR5 | CDHR2 | psi-mi:“MI:0407”(direct interaction) | 0.590 |
| CDHR5 | CDHR2 | psi-mi:“MI:0915”(physical association) | 0.590 |
| CDHR2 | CDHR5 | psi-mi:“MI:0915”(physical association) | 0.590 |
| CDHR2 | MAST2 | psi-mi:“MI:0915”(physical association) | 0.540 |
| MAST2 | CDHR2 | psi-mi:“MI:0915”(physical association) | 0.540 |
| MAST2 | CDHR2 | psi-mi:“MI:0403”(colocalization) | 0.540 |
| CDHR2 | USH1C | psi-mi:“MI:0915”(physical association) | 0.520 |
| USH1C | CDHR2 | psi-mi:“MI:0915”(physical association) | 0.520 |
| CDHR2 | MYO7B | psi-mi:“MI:0915”(physical association) | 0.460 |
| CDHR2 | MYO7B | psi-mi:“MI:0403”(colocalization) | 0.460 |
| GNAT3 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| RPS6KA2 | IPO7 | psi-mi:“MI:0914”(association) | 0.350 |
| RPS6KA6 | HMGN1 | psi-mi:“MI:0914”(association) | 0.350 |
| CDHR2 | HIP1R | psi-mi:“MI:0914”(association) | 0.350 |
| CDHR2 | CDHR5 | psi-mi:“MI:0403”(colocalization) | 0.270 |
| CDHR2 | USH1C | psi-mi:“MI:0403”(colocalization) | 0.270 |
BioGRID (15): MAST2 (Affinity Capture-Western), MAST2 (Co-localization), NF1 (Affinity Capture-MS), HIP1R (Affinity Capture-MS), MAST2 (Two-hybrid), MRS2 (Affinity Capture-MS), LAMB1 (Affinity Capture-MS), TMTC2 (Affinity Capture-MS), SURF1 (Affinity Capture-MS), FBXO2 (Affinity Capture-MS), TBCD (Affinity Capture-MS), LGALS1 (Affinity Capture-MS), CDHR2 (Affinity Capture-MS), CDHR2 (Affinity Capture-MS), NUP88 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: E9Q7P9, O88277, O93319, P55280, P55281, P55285, P55289, P70408, P79995, P97326, Q08DJ5, Q12864, Q13634, Q14517, Q24298, Q2PZL6, Q3SWX5, Q5DWV1, Q5DWV2, Q5F226, Q63315, Q6B3P0, Q6KEQ9, Q6V0I7, Q6WXV7, Q6WYY1, Q6X862, Q6ZTQ4, Q71M42, Q8BIZ0, Q8BL00, Q8BM92, Q8BNA6, Q8N6Y1, Q8QGH3, Q8R508, Q8TDW7, Q90762, Q90763, Q91838
Diamond homologs: B2KI42, E9Q7P9, O18926, O54800, O55075, O93319, P08641, P20310, P30944, P33147, P55280, P55284, P55286, P55287, P55288, P58365, P97291, P97326, Q2PZL6, Q3SWX5, Q63418, Q6B457, Q6PB90, Q6PFX6, Q767I8, Q86UP0, Q8AYD0, Q8UVJ7, Q8VHP6, Q8WN91, Q90762, Q90Z37, Q91XU7, Q91XZ4, Q96JP9, Q99PF4, Q9BYE9, Q9H251, Q9QYP2, D4ACX8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
281 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 228 |
| Likely benign | 26 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1707460 | Single allele | Pathogenic |
| 2579264 | GRCh38/hg38 5q35.2-35.3(chr5:176447531-177312407)x1 | Pathogenic |
SpliceAI
5205 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:176542770:G:GG | donor_gain | 1.0000 |
| 5:176568813:ACGAG:A | donor_loss | 1.0000 |
| 5:176568814:CGAGG:C | donor_loss | 1.0000 |
| 5:176568815:GAGGT:G | donor_loss | 1.0000 |
| 5:176568816:AGG:A | donor_loss | 1.0000 |
| 5:176568817:GGTA:G | donor_loss | 1.0000 |
| 5:176568818:G:GA | donor_loss | 1.0000 |
| 5:176568819:T:G | donor_loss | 1.0000 |
| 5:176568948:T:TA | acceptor_gain | 1.0000 |
| 5:176571298:ACGAG:A | donor_loss | 1.0000 |
| 5:176571300:GAGGT:G | donor_loss | 1.0000 |
| 5:176571301:AGGTG:A | donor_loss | 1.0000 |
| 5:176571302:GGTG:G | donor_loss | 1.0000 |
| 5:176571303:G:A | donor_loss | 1.0000 |
| 5:176571322:G:GA | donor_gain | 1.0000 |
| 5:176574080:CAGAC:C | acceptor_loss | 1.0000 |
| 5:176574081:A:C | acceptor_loss | 1.0000 |
| 5:176574082:GACC:G | acceptor_gain | 1.0000 |
| 5:176574169:GAAG:G | donor_gain | 1.0000 |
| 5:176574171:AGG:A | donor_loss | 1.0000 |
| 5:176574173:G:GC | donor_loss | 1.0000 |
| 5:176574174:T:A | donor_loss | 1.0000 |
| 5:176575082:A:AG | acceptor_gain | 1.0000 |
| 5:176575083:G:GG | acceptor_gain | 1.0000 |
| 5:176575083:GGTC:G | acceptor_gain | 1.0000 |
| 5:176575210:G:GG | donor_gain | 1.0000 |
| 5:176575387:G:GT | donor_gain | 1.0000 |
| 5:176575415:G:GT | donor_gain | 1.0000 |
| 5:176575422:CCAAG:C | donor_loss | 1.0000 |
| 5:176575423:CAAG:C | donor_loss | 1.0000 |
AlphaMissense
8585 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:176577451:T:C | F416S | 0.993 |
| 5:176576049:T:C | F353S | 0.992 |
| 5:176577644:C:A | A453D | 0.991 |
| 5:176584190:G:C | D687H | 0.991 |
| 5:176576043:C:A | P351H | 0.990 |
| 5:176578376:T:C | F529S | 0.990 |
| 5:176578505:T:C | L572P | 0.990 |
| 5:176589380:T:A | V1020D | 0.990 |
| 5:176589568:T:G | F1053C | 0.990 |
| 5:176576048:T:C | F353L | 0.989 |
| 5:176576050:T:A | F353L | 0.989 |
| 5:176576050:T:G | F353L | 0.989 |
| 5:176577450:T:C | F416L | 0.989 |
| 5:176577452:C:A | F416L | 0.989 |
| 5:176577452:C:G | F416L | 0.989 |
| 5:176589567:T:C | F1053L | 0.989 |
| 5:176589569:C:A | F1053L | 0.989 |
| 5:176589569:C:G | F1053L | 0.989 |
| 5:176571262:C:A | P122H | 0.988 |
| 5:176571268:T:G | F124C | 0.988 |
| 5:176574131:G:C | D152H | 0.988 |
| 5:176575953:C:A | A321D | 0.988 |
| 5:176577719:C:A | P478H | 0.988 |
| 5:176578468:G:C | A560P | 0.988 |
| 5:176584439:G:C | D720H | 0.988 |
| 5:176584476:T:C | F732S | 0.988 |
| 5:176589367:T:G | Y1016D | 0.988 |
| 5:176584440:A:C | D720A | 0.987 |
| 5:176589568:T:C | F1053S | 0.987 |
| 5:176574132:A:C | D152A | 0.986 |
dbSNP variants (sampled 300 via entrez): RS1000015036 (5:176588750 G>T), RS1000078586 (5:176552825 C>T), RS1000216487 (5:176575084 G>A), RS1000218139 (5:176574451 A>C), RS1000231844 (5:176548112 C>G,T), RS1000302468 (5:176557914 G>T), RS1000334272 (5:176563413 C>A), RS1000428310 (5:176591108 C>T), RS1000446015 (5:176569086 C>A,T), RS1000539911 (5:176549436 G>A), RS1000577895 (5:176563717 C>T), RS1000586514 (5:176596461 A>G), RS1000724603 (5:176579759 C>T), RS1000732135 (5:176580446 T>C), RS1000786103 (5:176595383 G>A)
Disease associations
OMIM: gene MIM:619713 | disease phenotypes: MIM:117550
GenCC curated gene-disease
Mondo (2): 5q35 microduplication syndrome (MONDO:0016461), Sotos syndrome (MONDO:0019349)
Orphanet (2): 5q35 microduplication syndrome (Orphanet:228415), Sotos syndrome (Orphanet:821)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008163_438 | Height | 3.000000e-06 |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D058495 | Sotos Syndrome | C16.131.077.889; C16.131.260.905; C16.320.180.905 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | decreases expression, increases expression | 3 |
| Benzo(a)pyrene | decreases expression, decreases methylation, affects methylation | 2 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| abrine | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Niclosamide | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT04993235 | Not specified | UNKNOWN | Body Perception and Representation in Overgrowth Syndromes, Behavioral Assessment and Neuropsychological Development |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): 5q35 microduplication syndrome, Sotos syndrome